Dr. Thomas McGinn answers questions on comorbidities that are key factors in the acuity of COVID-19
Dr. Thomas McGinn, the director of Health Innovations & Outcomes Research at Feinstein Institutes, spoke with News 12's Elizabeth Hashagen and answered COVID-19 questions from viewers.
•
Apr 29, 2020, 1:38 PM
•
Updated 1,918 days ago
Share:
Dr. Thomas McGinn, the director of Health Innovations & Outcomes Research at Feinstein Institutes, spoke with News 12's Elizabeth Hashagen and answered COVID-19 questions from viewers.
Dr. McGinn was co-author on a JAMA paper about a study that linked hypertension, obesity and diabetes as comorbidities (the simultaneous presence of two chronic diseases or conditions in a patient) as key factors in the acuity of COVID-19 in some patients.
More from News 12
1:50
Lost and Found: Fire Island postmaster reunites firefighter with charm
2:16
HEAT ALERT: Extreme heat continues; cooler at South Shore beaches
1:39
Around 250 patients file lawsuit against Northwell Health over alleged illegal surveillance at Great Neck facilities
0:32
Funeral services to be held Friday for man pulled into MRI machine in Nassau
1:51
LI food banks report immigrants avoiding food pantries due to ICE fears
0:49
